Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comorbid anxiety and depression.

Mark H Pollack1

  • 1Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 02114, USA. mpollack@partners.org

The Journal of Clinical Psychiatry
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring study dropout in drug trials for adults with PTSD: insights from a conventional and individual participant data meta-analysis.

European journal of psychotraumatology·2025
Same author

Brain derived neurotrophic factor and treatment outcomes among veterans attending an intensive treatment program for posttraumatic stress disorder.

Journal of psychiatric research·2024
Same author

What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder.

Behaviour research and therapy·2023
Same author

Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT.

Journal of psychiatric research·2023
Same author

Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety.

BMC psychiatry·2022
Same author

Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.

American journal of physiology. Gastrointestinal and liver physiology·2022
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Anxiety and depression frequently co-occur, impacting treatment outcomes. Effective management involves selective serotonin reuptuptake inhibitors, with augmentation therapies like cognitive-behavioral therapy offering additional benefits.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Anxiety and depressive disorders often present as comorbid conditions.
  • These disorders share common symptoms and are influenced by genetic and environmental risk factors.
  • Comorbidity negatively impacts patient prognosis and treatment effectiveness.

Purpose of the Study:

  • To review the clinical implications of comorbid anxiety and depression.
  • To discuss current and alternative therapeutic strategies for managing these conditions.

Main Methods:

  • Literature review of studies on anxiety and depression comorbidity.
  • Analysis of treatment outcomes for various pharmacological and psychotherapeutic interventions.

Main Results:

Related Experiment Videos

  • Selective serotonin reuptake inhibitors (SSRIs) are primary treatments.
  • Augmentation therapies including benzodiazepines, anticonvulsants, atypical antipsychotics, buspirone, and beta-blockers show potential benefits.
  • Cognitive-behavioral therapy (CBT) is an effective alternative treatment.

Conclusions:

  • Comorbid anxiety and depression require comprehensive treatment strategies.
  • Pharmacological interventions, including SSRIs and augmentation agents, are crucial.
  • Psychotherapeutic approaches like CBT offer valuable alternatives and adjuncts for optimizing patient outcomes.